Authors




Kevin Cleveland, PharmD

Latest:

Q&A: How ACIP Changes Could Reshape Patient Care

Kevin W. Cleveland, PharmD, urges evidence-based approaches to immunizations in an era of uncertainty.


Sobha Pisharody

Latest:

The Increasingly Relevant Role of Pharmacogenomics

Pharmacogenomics looks at how genetic influences affect an individual’s response to therapeutic medications.


Anam Jalaluddin

Latest:

How Technology Can Reduce Pharmacy Staff Burnout

Companies like ShiftRx are using technology to help solve the staffing shortage crisis in health care.



Jenny Zhao, PharmD

Latest:

FDA Approves Ceftobiprole Medocaril Sodium for 3 Indications

The FDA approved ceftobiprole medocaril sodium for injection (Zevtera) in April 2024.



Becky Davis

Latest:

Asembia Does a Great Job Bringing Professionals Together, Experts Say | Asembia 2025

The Summit provides a rare opportunity for professionals to dive deep into emerging healthcare technologies and treatment models.


Beth Brooks, PhD, RN, FACHE

Latest:

Health Care Hiring Trends For 2023 And Beyond

How are hiring trends shaping up for the future of health care?


Kevin Chamberlain, PharmD, FASCP

Latest:

Lecanemab-irmb Approved for Alzheimer Disease

On January 6, 2023, the FDA granted lecanemab-irmb (Leqembi) accelerated approval for treating mild cognitive impairment and mild dementia in patients with Alzheimer disease.


Andre Wang, PharmD

Latest:

New Prodrug for ADHD in School-aged Children

Ser/dex is a dexmethylphenidate-based prodrug for ADHD in patients 6 years and older.


Yi Deng, PhD

Latest:

Q&A: What AI Is, How It’s Helping Pharmacies with Compliance | NCPDP 2025

Stanley V. Campbell, Jr., CEO of EagleForce Associates, Inc., and Yi Deng, PhD, Senior Vice President of Engineering at EagleForce, discuss the basics of AI and how it’s assisting with compliance.


Satish Srinivasan, MS

Latest:

Could a Cash-Based System Help Eliminate Health Care Barriers?

Disadvantaged groups are feeling the sting of health care costs—so much so that many are foregoing health care because they can’t pay for it.


Tim Gregorius, RPh

Latest:

Use This Checklist To Select Your CBD Product

What pharmacists need to consider before selling CBD in their stores.


Alana Galipeau, PharmD Candidate

Latest:

OTC Considerations for COVID-19

Many individuals have been asking if they can take things at home, such as vitamins and OTC medications, to decrease their risk of contracting the virus or to self-treat themselves


Ruby Barghini, MD

Latest:

Apetamin Gains Popularity on Social Media as Weight Gain Drug

Apetamin has been promoted worldwide as a weight gain supplement—but what are the dangers of misuse?


Lisa Faast, PharmD, DiversifyRx CEO

Latest:

How to Increase CBD Sales at Your Independent Pharmacy

Tips to help your pharmacy stand out as a knowledgeable CBD retailer.


Madison Irwin, PharmD, BCPS

Latest:

Pharmacists Help Patients Manage Chronic Pain

Chronic pain is associated with a significant financial burden, with an estimated cost placed at $650 billion annually in the US.


Kendall Haney, PharmD Candidate

Latest:

COVID-19 Therapy Pipeline Update

Here’s an overview of what’s in the late-stage pipeline.



Richard Payerchin

Latest:

Opioid Use Disorder Treatment Inconsistent Around United States

At the state level, medication treatment rates ranged from 17.7% in Kansas to 82.8% in Maine.


Crystal Lennartz

Latest:

Independent Pharmacies Face Mounting Challenges in Modern Health Care Landscape | McKesson ideaShare

Crystal Lennartz, president of Health Mart & Health Mart Atlas at McKesson, discusses challenges that independent pharmacies are facing in today's health care landscape.


Lynda Charters

Latest:

AMD Risk Not Tied to Long-Term Metformin Use

The researchers reported that there was no significant difference in the age-related macular degeneration prevalence among the 3 study groups.



Razanne Oueini, PharmD, MSc, CPHQ

Latest:

Q&A: Insulin Cost Cap Linked to Better Treatment Persistence | PQA 2025

Razanne Oueini, PharmD, MSc, CPHQ, discusses how rates of persistence to basal insulin were impacted after the IRA monthly cap.


Brandon May

Latest:

Mitigating Costs of Cancer Treatment: The Role of Pharmacists

Cancer care is expensive, but pharmacists can help.


Heather Raglin

Latest:

Anti-PD-1 Therapy for Melanoma Associated With Chronic Immune-Related Adverse Events

The majority of persistent irAEs were hypothyroid, adrenal insufficiency, arthritis, dermatitis or pruritis, and hypophysitis.


Sara Elsaid Taha, BPS, PharmD Candidate 2022

Latest:

Vitamin D and COVID-19: An Evidence-Based Review

In this article, we will review the evidence describing a possible link between vitamin D and COVID-19.


Miguel Rodriguez, JD

Latest:

Maximum (Un)Fair Price

How pharmacies will pay for the Medicare Drug Price Negotiation Program

© 2025 MJH Life Sciences

All rights reserved.